PHASE 2, SINGLE ARM CLINICAL TRIAL TO EVALUATE THE SAFETY AND ACTIVITY OF OREGOVOMAB AND NIRAPARIB IN SUBJECTS WITH PLATINUM SENSITIVE RECURRENT OVARIAN CANCER: FLORA-4

Zejula (niraparib) - GSK, J&J, Takeda

paclitaxel - Generic mfg.

carboplatin - Generic mfg.

OvaRex (oregovomab) - CanariaBio

Linda Duska1; Debra Richardson2; Srinivasa Rao Jada3; Sunil Gupta3; Tl Raj Teja3; Angeles Alvarez Secord4

Oct 25, 2023